Creative Planning’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$255K Buy
+10,483
New +$255K ﹤0.01% 3026
2025
Q1
Sell
-665
Closed -$15.7K 3453
2024
Q4
$15.7K Sell
665
-9,072
-93% -$214K ﹤0.01% 3343
2024
Q3
$249K Sell
9,737
-1,117
-10% -$28.6K ﹤0.01% 2684
2024
Q2
$255K Buy
10,854
+1,301
+14% +$30.5K ﹤0.01% 2485
2024
Q1
$275K Sell
9,553
-6,101
-39% -$175K ﹤0.01% 2313
2023
Q4
$514K Buy
15,654
+2,583
+20% +$84.7K ﹤0.01% 1696
2023
Q3
$364K Sell
13,071
-1,244
-9% -$34.7K ﹤0.01% 1778
2023
Q2
$488K Buy
14,315
+3,961
+38% +$135K ﹤0.01% 1558
2023
Q1
$311K Sell
10,354
-2,610
-20% -$78.5K ﹤0.01% 1788
2022
Q4
$366K Sell
12,964
-3,168
-20% -$89.4K ﹤0.01% 1585
2022
Q3
$530K Buy
16,132
+341
+2% +$11.2K ﹤0.01% 1292
2022
Q2
$497K Sell
15,791
-2,656
-14% -$83.6K ﹤0.01% 1312
2022
Q1
$847K Sell
18,447
-1,350
-7% -$62K ﹤0.01% 1068
2021
Q4
$1.21M Sell
19,797
-717
-3% -$43.9K ﹤0.01% 868
2021
Q3
$1.53M Sell
20,514
-2,984
-13% -$223K ﹤0.01% 766
2021
Q2
$2.17M Sell
23,498
-7,515
-24% -$695K ﹤0.01% 649
2021
Q1
$2.75M Buy
31,013
+9,324
+43% +$827K 0.01% 590
2020
Q4
$2.02M Buy
21,689
+9,643
+80% +$899K ﹤0.01% 660
2020
Q3
$767K Buy
+12,046
New +$767K ﹤0.01% 903